PLD regulates myoblast differentiation through the mTOR-IGF2 pathway

Mee Sup Yoon, Jie Chen

Research output: Contribution to journalArticle

Abstract

A mammalian target of rapamycin (mTOR) pathway is essential for the differentiation of cultured skeletal myoblasts in response to growth factor withdrawal. Previously, phospholipase D (PLD) has been found to play a role in cell growth regulation and mitogenic activation of mTOR signaling. However, a role for PLD in the autocrine regulation of myoblast differentiation is not known. Here we show that upon induction of differentiation in mouse C2C12 satellite cells, the expression of both PLD1 and PLD2 is upregulated. C2C12 differentiation is markedly inhibited by 1-butanol, an inhibitor of the PLD-catalyzed transphosphatidylation reaction, and also by the knockdown of PLD1, but not PLD2. Further investigation has revealed that PLD1 is unlikely to regulate myogenesis through modulation of the actin cytoskeleton as previously suggested. Instead, PLD1 positively regulates mTOR signaling leading to the production of IGF2, an autocrine factor instrumental for the initiation of satellite cell differentiation. Furthermore, exogenous IGF2 fully rescues the differentiation defect resulting from PLD1 knockdown. Hence, PLD1 is critically involved in skeletal myogenesis by regulating the mTOR-IGF2 pathway.

Original languageEnglish (US)
Pages (from-to)282-289
Number of pages8
JournalJournal of cell science
Volume121
Issue number3
DOIs
StatePublished - Feb 1 2008

    Fingerprint

Keywords

  • Myogenesis
  • Phospholipase D (PLD)
  • mTOR

ASJC Scopus subject areas

  • Cell Biology

Cite this